Based on the appearance economy, play the leading role of Lixiu industry, and build a new paradigm for expansion development

At the moment when the "beauty economy" is becoming more and more popular, the medical beauty market in China is setting off a new round of consumption boom. At the macro level, the post epidemic era saw economic recovery and the release of pent up consumer demand, providing strong support for the growth of the medical and beauty market; At the meso level, the intensive introduction of medical and aesthetic related policies and the continuous influx of industrial capital have created a good industrial environment for the development of the medical and aesthetic industry; At the micro level, with the improvement of living standards, people hope to please themselves to a greater extent, and "happy consumption" has become a common practice. With the continuous emergence of various new products and technologies, the medical beauty market in China is experiencing explosive growth.

From simple skin care to complex plastic surgery, the Chinese medical beauty market has formed a closed-loop industrial chain from upstream raw material suppliers, to midstream equipment manufacturers, to downstream medical beauty service institutions and C-end medical beauty consumers. Although they are in the same industrial chain, the fate of upstream and downstream enterprises of Yimei is quite different. Although in the long run, the value of each link of the medical and aesthetic industry chain is still possible to be redistributed, in the existing distribution pattern, the midstream device manufacturers have great advantages in price negotiation by virtue of high technical barriers and qualification thresholds, and are the most concentrated link in the value distribution of the medical and aesthetic industry chain.

Medical device products have dual attributes of medical treatment and consumption, including instruments, equipment and appliances directly or indirectly used for human body, as well as implants, calibrators, in vitro diagnostic reagents and other materials. As the core of the medical beauty industry chain, there are certain technical, patent and qualification thresholds for medical devices. At the same time, strong marketing and channel investment are needed to expand the market. Throughout the development of medical devices, leading enterprises have both profound product attainments and deep market perception. But different enterprise genes have created different brand strategies for these leading enterprises.

For example, the popular face filling material - expanded polytetrafluoroethylene, with its good biocompatibility, plasticity and excellent fixation effect brought by the "special" microporous structure, is widely used in the field of medical beauty. As the first enterprise in China to establish an expansion production line and to apply expansion to the medical field, Shanghai Suokang Medical Materials Co., Ltd. (hereinafter referred to as "Suokang") is an evergreen and leading brand in the field of expansion materials.

Relying on a strong independent research and development team and the accumulation of numerous clinical cases, Suokang has profound achievements in the research, development and manufacturing of expanded materials. In 2005, Suokang's first expanded body brand "Lixiu" came into the market. While giving full play to the advantages of first release in the market, Lixiu has been in a leading position in the domestic bulking market for a long time with its excellent quality and continuous innovation in product dimensions.

With the renewal of the concept of medical beauty and the improvement of the aesthetic level of the public, consumers' requirements for medical beauty materials are also constantly improving. The safe, lasting and natural facial shaping effect has become the new focus of the market. In this regard, Suokang continues to optimize the production process and constantly promote product innovation. From the early expansion with binder to the "pure expansion" without binder (FEP) and other impurities; From flaky and blocky prostheses to "preformed bulks" that can be implanted simply by carving (or even without carving), Sokon has filled many technical gaps in the industry, and at the same time, it has also achieved the technological breakthrough of domestic brands in the field of bulking technology against imported brands such as Emiliant.

In terms of expansion material development and market expansion, Suokang also has unique views. As a highly professional industry, medical beauty often has information barriers between manufacturers and consumers. Compared with other industries, the product power of medical devices is more difficult to be perceived by consumers, and manufacturers are also difficult to understand consumers' pain points. Through holding various industry exchange activities, Suokang has reached cooperation with well-known hospitals and doctors, widely collected clinical feedback, and transformed it into research and development momentum. In view of the current hot issues such as bone beauty, Suokang has deeply explored the market demand. According to the facial characteristics of East Asians, combined with the facial shaping characteristics of eyebrow arch and nasal base, Suokang has created new brands such as "Liyan" and "Bangyan", and expanded new product application fields and market space.

Under the background of the beauty economy driving the development of the medical beauty market, as the core of the medical beauty industry chain, medical devices will also usher in a broader development future. After 23 years of development, Suokang has owned several puff brands, such as Lixiu, Liyan, Bangyan, and more than 50 technical patents. It is a well deserved domestic puff leader. In the future, Suokang will also continue to adhere to the core idea of "Let quality speak for China", provide consumers with better products and services, and help the medical and aesthetic industry continue to prosper.

key word: